新冠疫情期间异位妊娠的超声特征、血清生化及结局
该回顾性研究分析了伦敦一家中心2019年与2020年经阴道超声诊断的异位妊娠(EP)病例,比较疫情前后的临床、超声及生化特征。结果显示两年EP诊断比例相似(均约1%),EP位置、大小、形态及诊断时孕周无差异,但2020年诊断时血清hCG更高(1005 IU/L vs 665 IU/L,P=0.03),一线保守治疗失败率更高(16% vs 6%,P=0.01)。
要点
- 疫情期间EP诊断比例与疫情前相似,未发现诊断延迟。
- 2020年EP诊断时血清hCG水平显著高于2019年。
- 一线保守治疗失败率疫情期间更高(16% vs 6%)。
核心结论
- 疫情前后EP的位置、大小、形态及诊断时孕周无差异,并发症率和最终管理策略亦无变化。
- 但疫情期间诊断时hCG水平更高,且一线保守治疗失败率更高。
研究设计与样本
- 回顾性分析2019年1月1日至2020年12月31日在伦敦一家中心经阴道超声诊断的EP病例。
主要发现
- 两组年龄、 ethnicity、体重及受孕方式可比,首次超声和诊断时孕周相似,EP位置、大小、形态无差异。
- 2020年诊断时血清hCG为1005 IU/L,2019年为665 IU/L(P=0.03)。
- 一线管理失败率2020年为16%,2019年为6%(P=0.01)。
- 超声盆腔积血率2019年23%、2020年26%(P=0.58),手术证实破裂率2019年3%、2020年9%(P=0.07)。
临床怎么用
- 疫情期间EP患者仍能获得适当诊疗,未发现诊断延迟或不良结局增加。
- 临床需注意疫情期间EP诊断时hCG可能更高,保守治疗失败风险增加。
局限性
- 单中心回顾性研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe and compare the characteristics of ectopic pregnancies (EPs) in the year prior to vs during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: This was a retrospective analysis of women diagnosed with an EP on transvaginal sonography conducted at a center in London, UK, providing early-pregnancy assessment, between 1 January 2019 and 31 December 2020. Women were identified via the Astraia ultrasound reporting system using coded and non-coded outcomes of EP or pregnancy outside the uterine cavity. Data related to predefined outcomes were collected using Astraia and Cerner electronic reporting systems. Main outcome measures included clinical, ultrasound and biochemical features of EP, in addition to reported complications and management. RESULTS: There were 22 683 consultations over the 2-year period. Following consultation, a similar number and proportion of EPs were diagnosed in 2019 (141/12 657 (1%)) and 2020 (134/10 026 (1%)). Both cohorts were comparable in age, ethnicity, weight and method of conception. Gestational age at the first transvaginal sonography scan and at diagnosis were similar, and no difference in location, size or morphology of EP was found between the two cohorts. Serum human chorionic gonadotropin (hCG) levels at the time of EP diagnosis were higher in 2020 than in 2019 (1005 IU/L vs 665 IU/L; P = 0.03). The proportions of women according to type of final EP management were similar, but the rate of failed first-line management was higher during vs before the pandemic (16% vs 6%; P = 0.01). The rates of blood detected in the pelvis (hemoperitoneum) on ultrasound (23% vs 26%; P = 0.58) and of ruptured EP confirmed surgically (9% vs 3%; P = 0.07) were similar in 2019 vs 2020. CONCLUSIONS: No difference was observed in the location, size, morphology or gestational age at the first ultrasound examination or at diagnosis of EP between women diagnosed before vs during the COVID-19 pandemic. Complication rates and final management strategy were also unchanged. However, hCG levels and the failure rate of first-line conservative management measures were higher during the pandemic. Our findings suggest that women continued to access appropriate care for EP during the COVID-19 pandemic, with no evidence of diagnostic delay or an increase in adverse outcome in our population. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Kyriacou C, Cooper N, Robinson E, et al. Ultrasound characteristics, serum biochemistry and outcome of ectopic pregnancies presenting during COVID-19 pandemic. Ultrasound Obstet Gynecol. 2021. PMID: 34605083. doi:10.1002/uog.24793
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。